Two Related Epstein-Barr Virus Membrane Proteins Are Encoded by Separate Genes

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 1989 Feb 1

PMID 2536113

Citations 73

Authors

J Sample

D Liebowitz

E Kieff

Affiliations

Soon will be listed here.

Abstract

The structures of the 2.3- and 2.0-kilobase Epstein-Barr virus (EBV) mRNAs, partially encoded within the EcoRI J fragment DNA of the viral genome, were determined by analysis of their cDNAs. Both mRNAs are transcribed across the fused terminal repeats of the EBV episome and consist of nine exons. The mRNAs are transcribed from different promoters and have a unique 5' exon from the U5 region of the genome but eight common exons from the U1 region. One principal open reading frame is present in each mRNA and is predicted to encode 54,000- and 40,000-dalton integral membrane proteins. This result was confirmed by in vitro translation of RNAs in the presence of canine pancreatic microsomes. The 2.3-kilobase mRNA is not expressed in Raji cells, owing to the deletion of the 5' regulatory and coding region of this gene, whereas neither mRNA is expressed in Namalwa cells, owing to inactivation as a result of integration of the EBV genome via the terminal repeats. Since these mRNAs are readily detected in largely latently infected cells and do not increase in abundance with EBV replication, these putative latent-infection membrane proteins are tentatively designated LMP-2A and LMP-2B, respectively.

Citing Articles

Generation of novel affibody molecules targeting the EBV LMP2A N-terminal domain with inhibiting effects on the proliferation of nasopharyngeal carcinoma cells.

Zhu J, Kamara S, Cen D, Tang W, Gu M, Ci X Cell Death Dis. 2020; 11(4):213.

PMID: 32238802 PMC: 7113277. DOI: 10.1038/s41419-020-2410-7.

Constructing TC-1-GLUC-LMP2 Model Tumor Cells to Evaluate the Anti-Tumor Effects of LMP2-Related Vaccines.

Sun L, Hao Y, Wang Z, Zeng Y Viruses. 2018; 10(4).

PMID: 29570629 PMC: 5923439. DOI: 10.3390/v10040145.

EBV and Apoptosis: The Viral Master Regulator of Cell Fate?.

Fitzsimmons L, Kelly G Viruses. 2017; 9(11).

PMID: 29137176 PMC: 5707546. DOI: 10.3390/v9110339.

Expression of the Antisense-to-Latency Transcript Long Noncoding RNA in Kaposi's Sarcoma-Associated Herpesvirus.

Schifano J, Corcoran K, Kelkar H, Dittmer D J Virol. 2016; 91(4).

PMID: 27928018 PMC: 5286886. DOI: 10.1128/JVI.01698-16.

The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma.

Tsang C, Tsao S Virol Sin. 2015; 30(2):107-21.

PMID: 25910483 PMC: 8200872. DOI: 10.1007/s12250-015-3592-5.

References

Wang F, Gregory C, Rowe M, Rickinson A, Wang D, Birkenbach M . Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. Proc Natl Acad Sci U S A. 1987; 84(10):3452-6. PMC: 304889. DOI: 10.1073/pnas.84.10.3452. View

Proudfoot N, Brownlee G . 3' non-coding region sequences in eukaryotic messenger RNA. Nature. 1976; 263(5574):211-4. DOI: 10.1038/263211a0. View

Lawrence J, Villnave C, Singer R . Sensitive, high-resolution chromatin and chromosome mapping in situ: presence and orientation of two closely integrated copies of EBV in a lymphoma line. Cell. 1988; 52(1):51-61. DOI: 10.1016/0092-8674(88)90530-2. View

Petti L, Sample J, Wang F, Kieff E . A fifth Epstein-Barr virus nuclear protein (EBNA3C) is expressed in latently infected growth-transformed lymphocytes. J Virol. 1988; 62(4):1330-8. PMC: 253145. DOI: 10.1128/JVI.62.4.1330-1338.1988. View

Petti L, Kieff E . A sixth Epstein-Barr virus nuclear protein (EBNA3B) is expressed in latently infected growth-transformed lymphocytes. J Virol. 1988; 62(6):2173-8. PMC: 253321. DOI: 10.1128/JVI.62.6.2173-2178.1988. View

Wang D, Liebowitz D, Wang F, Gregory C, Rickinson A, Larson R . Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity. J Virol. 1988; 62(11):4173-84. PMC: 253849. DOI: 10.1128/JVI.62.11.4173-4184.1988. View

Dambaugh T, Beisel C, Hummel M, King W, Fennewald S, Cheung A . Epstein-Barr virus (B95-8) DNA VII: molecular cloning and detailed mapping. Proc Natl Acad Sci U S A. 1980; 77(5):2999-3003. PMC: 349534. DOI: 10.1073/pnas.77.5.2999. View

Corden J, Wasylyk B, Buchwalder A, Sassone-Corsi P, Kedinger C, Chambon P . Promoter sequences of eukaryotic protein-coding genes. Science. 1980; 209(4463):1406-14. DOI: 10.1126/science.6251548. View

van Santen V, Cheung A, Kieff E . Epstein-Barr virus RNA VII: size and direction of transcription of virus-specified cytoplasmic RNAs in a transformed cell line. Proc Natl Acad Sci U S A. 1981; 78(3):1930-4. PMC: 319249. DOI: 10.1073/pnas.78.3.1930. View

10.

Hopp T, Woods K . Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci U S A. 1981; 78(6):3824-8. PMC: 319665. DOI: 10.1073/pnas.78.6.3824. View

11.

Mostov K, Defoor P, Fleischer S, Blobel G . Co-translational membrane integration of calcium pump protein without signal sequence cleavage. Nature. 1981; 292(5818):87-8. DOI: 10.1038/292087a0. View

12.

Mount S . A catalogue of splice junction sequences. Nucleic Acids Res. 1982; 10(2):459-72. PMC: 326150. DOI: 10.1093/nar/10.2.459. View

13.

Hummel M, Kieff E . Epstein-Barr virus RNA. VIII. Viral RNA in permissively infected B95-8 cells. J Virol. 1982; 43(1):262-72. PMC: 256117. DOI: 10.1128/JVI.43.1.262-272.1982. View

14.

POLACK A, Delius H, Zimber U, Bornkamm G . Two deletions in the Epstein-Barr virus genome of the Burkitt lymphoma nonproducer line Raji. Virology. 1984; 133(1):146-57. DOI: 10.1016/0042-6822(84)90433-1. View

15.

Fennewald S, van Santen V, Kieff E . Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein. J Virol. 1984; 51(2):411-9. PMC: 254453. DOI: 10.1128/JVI.51.2.411-419.1984. View

16.

Baer R, Bankier A, Biggin M, Deininger P, Farrell P, Gibson T . DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature. 1984; 310(5974):207-11. DOI: 10.1038/310207a0. View

17.

Hennessy K, Fennewald S, Hummel M, Cole T, Kieff E . A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection. Proc Natl Acad Sci U S A. 1984; 81(22):7207-11. PMC: 392107. DOI: 10.1073/pnas.81.22.7207. View

18.

Matsuo T, Heller M, Petti L, Oshiro E, Kieff E . Persistence of the entire Epstein-Barr virus genome integrated into human lymphocyte DNA. Science. 1984; 226(4680):1322-5. DOI: 10.1126/science.6095452. View

19.

Yates J, Warren N, Sugden B . Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature. 1985; 313(6005):812-5. DOI: 10.1038/313812a0. View

20.

Klein P, Kanehisa M, Delisi C . The detection and classification of membrane-spanning proteins. Biochim Biophys Acta. 1985; 815(3):468-76. DOI: 10.1016/0005-2736(85)90375-x. View